© 2021 MJH Life Sciences and Contagion Live. All rights reserved.
© 2021 MJH Life Sciences™ and Contagion Live. All rights reserved.
August 01, 2021
What are the efforts being made with antibiotic stewardship and treatments, and what areas in clinical care do medical professionals want to see improvements.
July 30, 2021
A conversation with Anna Legreid Dopp, Pharm. D.
July 23, 2021
A discussion as to why people with unstable housing living with HIV may not prefer telehealth versus consistent in-person care.
The risk of COVID-19 severity in people living with HIV may be less than previously anticipated.
Phase 3 trials for islatravir are underway. What are investigators considering with the Merck investigative drug?
July 22, 2021
Investigators wanted to study usage of F/TAF vs F/TDF in clinical practice and HIV seroconversion.
July 20, 2021
New 24-week findings from Merck highlight the potential of a 1-month PrEP option for low-risk patients.
July 19, 2021
The Pasteur Act in Congress is designed to incentivize pharmaceutical companies to develop new antibiotics.
July 18, 2021
Investigators surveyed men who have sex with men (MSM) about long-acting injectable pre-exposure prophylaxis (PrEP) including attitudes towards potentially taking it and barriers to usage.
Perspective gained from persons treated a real-world clinic may help better inform strategies to treat an HIV population that often struggles with viral suppression and consistent care.